Abstract
LBP-24 - Safety and efficacy of anti-pre-S1 domain monoclonal antibody (HH-003) treatment in patients with co-infection of chronic hepatitis B virus (HBV) and hepatitis D virus (HDV): a single center, open-label, phase 2 trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have